Results 221 to 230 of about 9,120,435 (385)

Spatio-temporal epidemiology of animal and human rabies in northern South Africa between 1998 and 2017

open access: gold, 2022
Kgaogelo Mogano   +8 more
openalex   +2 more sources

Distinct S-adenosylmethionine synthases link phosphatidylcholine to mitochondrial function and stress survival. [PDF]

open access: yesPLoS Biol
Munden AL   +20 more
europepmc   +1 more source

A low cost treadmill for experimental animals [PDF]

open access: yes, 1954
BAKER, B, KOUWENHOVEN, WB, STARZL, TE
core   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

open access: yesMolecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak   +4 more
wiley   +1 more source

Plasmid-mediated colistin resistance from fresh meat and slaughtered animals in the Czech Republic: nation-wide surveillance 2020–2021

open access: gold, 2023
Petra Sismova   +7 more
openalex   +1 more source

Instrumental Reasoning in Nonhuman Animals [PDF]

open access: yes, 2017
Camp, Elisabeth, Shupe, Eli
core  

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer

open access: yesMolecular Oncology, EarlyView.
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad   +35 more
wiley   +1 more source

Home - About - Disclaimer - Privacy